 Context Therapeutics NASDAQ:CNTX Inc said it has completed its previously-announced private placement, raising gross proceeds of about 31.3 million, before deducting offering expenses, by issuing 5 million of its common shares together with 5 million common share purchase warrants. Each share of the offering and accompanying warrant were sold at a combined offering price of 6.25, with the warrants having a five and one-half year term and an exercise price of 6.25 per share. 